Project Manager, Clinical Development
What are your responsibilities at Kura?
As Project Coordinator of Drug Development at Kura, I support the planning efforts of the development team, or other ad hoc cross-functional teams, to implement the development strategy and operational plan. I provide organizational and project management support for the execution of team strategies.
What excites you most about your work?
I enjoy working with the internal development teams at Kura. Everyone has passion for executing their work packages at the highest standard, and everyone believes in the mission.
What attracted you to working at Kura?
Precision medicine is an exciting and fascinating part of the oncology world. The FDA recently approved a drug, based upon the presence of a biomarker (not based on the tissue of origin). I believe we need to continue to seek out the promise of precision medicine in oncology.
What’s unique or special about Kura’s culture/environment?
Teamwork is an integral part to interpersonal relationships at Kura. People trust one another to give, listen and act on mutual feedback. As a result, everyone is able to improve, and the team thrives.
What’s the most fun or rewarding project you’ve worked on?
Tipifarnib, HNSCC is a rewarding project to coordinate. We recently had a positive Phase 2 trial in our tipifarnib program in patients with HRAS mutant HNSCC, as we achieved our primary endpoint before completion of enrollment. This patient population has an estimated survival of approximately 6-8 months, and our trial has already observed objective responses of greater than a year in 2 patients.
What is something that most people don’t know about you?
I’ve played piano since I was 6. I was trained to play classical piano, and it’s definitely one of my favorite pastimes.
Kura Oncology, Inc. (Headquarters)
3033 Science Park Road, Suite 220
San Diego, CA 92121
Kura Oncology, Inc. (Clinical Development)
55 Cambridge Parkway, Suite 101
Cambridge, MA 02142
Disclaimer: The information you have requested is not provided by Kura Oncology but by a third party and is not intended to be relied on for investment purposes. Kura Oncology does not guarantee the accuracy or completeness of this information and is not liable for any delays, inaccuracies, errors in, or omissions of any such information, or for any actions taken in reliance on this information, or for any damages arising therefrom